1. Home
  2. CLH vs ELAN Comparison

CLH vs ELAN Comparison

Compare CLH & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clean Harbors Inc.

CLH

Clean Harbors Inc.

HOLD

Current Price

$261.50

Market Cap

11.0B

Sector

Industrials

ML Signal

HOLD

Logo Elanco Animal Health Incorporated

ELAN

Elanco Animal Health Incorporated

HOLD

Current Price

$24.91

Market Cap

10.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLH
ELAN
Founded
1980
1954
Country
United States
United States
Employees
N/A
N/A
Industry
Environmental Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.0B
10.3B
IPO Year
1987
2018

Fundamental Metrics

Financial Performance
Metric
CLH
ELAN
Price
$261.50
$24.91
Analyst Decision
Buy
Buy
Analyst Count
12
10
Target Price
$259.25
$24.44
AVG Volume (30 Days)
391.2K
4.6M
Earning Date
02-18-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
7.20
0.07
Revenue
$5,962,257,000.00
$4,591,000,000.00
Revenue This Year
$2.85
$7.25
Revenue Next Year
$3.85
$5.69
P/E Ratio
$36.33
$343.18
Revenue Growth
2.85
3.08
52 Week Low
$178.29
$8.02
52 Week High
$268.22
$24.98

Technical Indicators

Market Signals
Indicator
CLH
ELAN
Relative Strength Index (RSI) 64.55 66.71
Support Level $255.67 $23.67
Resistance Level $264.26 $24.98
Average True Range (ATR) 6.76 0.81
MACD 0.76 0.10
Stochastic Oscillator 78.92 89.06

Price Performance

Historical Comparison
CLH
ELAN

About CLH Clean Harbors Inc.

Clean Harbors Inc is an environmental and industrial services provider. It provides parts cleaning and related environmental services to commercial, industrial, and automotive customers. Its business segments are Environmental Services and Safety-Kleen Sustainability Solutions. The company generates the majority of its revenues from the Environmental Services segment.

About ELAN Elanco Animal Health Incorporated

Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.

Share on Social Networks: